Type 2 diabetes linked to a family of metabolic genes

July 28, 2003

BOSTON -- An ambitious and exhaustive genetic study, led by investigators at the Joslin Diabetes Center and the Children's Hospital Boston Informatics Program, has pinpointed a group of genes that are involved in type 2 diabetes and shows that the activity of these genes changes even before overt diabetes develops. The study appears in a July 2003 edition of the Proceedings of the National Academy of Sciences (1).

The investigators at Joslin, led by Dr. Mary-Elizabeth Patti, an endocrinologist and scientist and director of the Genomics Laboratory at Joslin, wanted to identify genes that might be altered in people with diabetes and in those at high risk for the development of diabetes. To do this, they used a microarray - a small slide dotted with small pieces of DNA - to simultaneously measure the activity of over 7,000 genes in muscle tissue from Mexican-Americans, an ethnic group with a very high risk for diabetes. They compared three groups: subjects with diabetes, healthy subjects without diabetes, and high-risk subjects with "prediabetes" (diabetes in family members).

"Knowing which genes are turned on or off in people before they develop diabetes is a key piece of information needed to solve the puzzle of diabetes, and to identify new ways to treat and prevent this devastating disease," Dr. Patti explains.

Two genes, PCG1-alpha and PCG1-beta, showed reduced activity (also known as expression) not only in the people with diabetes, but also in those with prediabetes. This decreased activity appeared to lead to reduced activity of a larger group of genes involved in the metabolism of fats and carbohydrates. These genes code for proteins in the mitochondria, cell structures that play a critical role in energy metabolism. Reduced activity or expression of these genes may tip the scales to insulin resistance, or an inability of the body's cells to use insulin properly -- the first metabolic defect on the road to type 2 diabetes.

The investigators used bioinformatics techniques to hone in on the relevant genes from the initial 7,000 measured, explains co-investigator Dr. Atul Butte of the Children's Hospital Informatics Program (CHIP). The CHIP team also applied statistical techniques to adjust for various technical challenges, such as changes in scanner and chip technology during the course of the study.

The investigators first compared patterns of gene expression in people with diabetes versus the nondiabetics, and found that 187 genes were expressed differently between the two groups. Next, they compared the nondiabetics with the prediabetics, and found differences in expression for 166 genes. Further analysis found that 55 genes showed up in both comparisons - their activity was altered in both the diabetics and the prediabetics.

"That 55 is a valuable list of changes that are going on in the prediabetics, and should be studied further," says Dr. Butte. "What's interesting is that we can see these changes in gene expression even before the diagnosis of diabetes is made. This tells us that the process of getting to diabetes may be a continuum."

The hardest part of the study, which took three years to complete, was to make biological sense of the data on gene activity, notes Dr. Butte. "Even after you have a list of genes that are different between those with diabetes and nondiabetics, what does that pattern mean?" he asks. "In the end, what you're dealing with isn't genes, it's explanation." Dr. Butte's goal is to improve bioinformatics tools for diabetes research so that they incorporate what's known biologically about diabetes. "In this study, the microarrays were crucial, but you can't analyze these arrays without the context of the biology," he says. "That reasoning can't yet be done by computers."

Through repeated examination of the list of genes, integration of medical and scientific information, and educated guesses, Dr. Patti came to the realization that many of the genes altered in diabetes encode for proteins in the mitochondria, and that the majority is regulated by another gene known as NRF-1. That gave the clue to look at PCG-1 alpha and beta, genes that work with NRF-1 and may function as master controllers for many metabolic genes important in insulin resistance and diabetes.

"This information is quite exciting, since it provides direction for additional critical research to test new hypotheses about the role of these genes in development of diabetes," says Dr. Patti. "More importantly, if we can identify people at high risk for diabetes and learn to prevent these changes from taking place, we may be able to find better methods for both treatment and prevention of diabetes."

Because a number of genes on the list are known to be affected by exercise and obesity, the researchers propose that factors like inactivity and overeating may increase diabetes risk in genetically susceptible people by altering the expression of metabolic genes. Adds Dr. Patti, "Until we solve the final puzzle related to these genes, the good news is that healthy eating, exercise, and some medications are effective tools to both prevent and control diabetes."
The research was supported by the National Institutes of Health, the Endocrine Fellows Foundation, the Lawson Wilkins Pediatric Endocrinology Society, the Iacocca Foundation, the American Diabetes Association, and Harvard Medical School.

About Joslin Diabetes Center

Joslin Diabetes Center, established in Boston in 1898, is the foremost diabetes research, care and education center in the world. Joslin conducts the world's largest academic diabetes research effort, with a research team of over 300 people supported by $40 million in research funds. Joslin Clinic is dedicated to providing the best in treatment and education for individuals with type 1 (insulin dependent), type 2 (adult onset) diabetes and related complications. An affiliate of Harvard Medical School, physicians worldwide turn to Joslin for continuing medical education and e-learning. In addition to its headquarters in Boston's Longwood Medical Area, Joslin has affiliated treatment centers across the nation. For more information about Joslin and its programs, call 1-800-JOSLIN-1 or visit Joslin's Web site at www.joslin.org.

About Children's Hospital Boston

Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults for over 100 years. More than 500 scientists, including seven members of the National Academy of Sciences, nine members of the Institute of Medicine and nine members of the Howard Hughes Medical Institute comprise Children's research community. Children's is also the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital visit: www.childrenshospital.org.

(1) Patti ME, Butte AJ, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci 2003 July 8, 100:8466-71.

Joslin Diabetes Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.